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Abstract: In this paper, we present the first highly porous gold (h-PG) microneedles-based
second-generation biosensor for minimally invasive monitoring of glucose in artificial interstitial
fluid (ISF). A highly porous microneedles-based electrode was prepared by a simple electrochemical
self-templating method that involves two steps, gold electrodeposition and hydrogen bubbling
at the electrode, which were realized by applying a potential of −2 V versus a saturated calomel
electrode (SCE). The highly porous gold surface of the microneedles was modified by immobilization
of 6-(ferrocenyl)hexanethiol (FcSH) as a redox mediator and subsequently by immobilization of a
flavin adenine dinucleotide glucose dehydrogenase (FAD-GDH) enzyme using a drop-casting method.
The microneedles-based FcSH/FAD-GDH biosensor allows for the detection of glucose in artificial
interstitial fluid with an extended linear range (0.1–10 mM), high sensitivity (50.86 µA cm−2 mM−1),
stability (20% signal loss after 30 days), selectivity (only ascorbic acid showed a response about 10% of
glucose signal), and a short response time (3 s). These properties were favourably compared to other
microneedles-based glucose biosensors reported in the literature. Finally, the microneedle-arrays-based
second-generation biosensor for glucose detection was tested in artificial interstitial fluid opportunely
spiked with different concentrations of glucose (simulating healthy physiological conditions while
fasting and after lunch) and by placing the electrode into a simulated chitosan/agarose hydrogel skin
model embedded in the artificial ISF (continuous glucose monitoring). The obtained current signals
had a lag-time of about 2 min compared to the experiments in solution, but they fit perfectly into the
linearity range of the biosensor (0.1–10 mM). These promising results show that the proposed h-PG
microneedles-based sensor could be used as a wearable, disposable, user-friendly, and automated
diagnostic tool for diabetes patients.
Keywords: microneedles; porous gold; glucose; interstitial fluid; minimally invasive
1. Introduction
Optimal diabetes management requires accurate real-time monitoring of glucose. People with
diabetes have to test their blood sugar level several times every day to know how different foods,
medications, and activities may affect it [1,2]. The normal blood glucose level (tested while fasting) for
non-diabetics should be between 3.9 and 7.1 mmol/L (70–130 mg/dL). The mean normal blood glucose
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level in humans is about 5.5 mmol/L. However, this level fluctuates throughout the day. The common
method for monitoring glucose concentrations involves sampling of a small amount of blood, usually
from a fingertip, using a lancet that lightly pricks the skin, with discomfort for the patient, especially in
children or elderly people. Several commercial glucose meters based on amperometric electrochemical
technology have been realized to help patients manage blood glucose routine testing; however, they
provide just a single glucose reading and require repeated finger pricks [3,4].
In order to avoid this problem, commercially available glucose monitoring devices (CGMs) have
been developed that can provide real time, dynamic glucose information every five minutes [5].
The sensor is placed just under the skin and can be used for up to 10 days, requiring patients to remove
and reinsert a new sensor into subcutaneous tissue in another part of the body [6]. They are based on
glucose oxidase (GOx) and continuously measure glucose levels in the interstitial fluid (ISF) using a
needle that penetrates into the subcutaneous tissue. Glucose concentrations in capillary bloods are the
same as in the ISF with a mean lag time of 6–7 min [7–9]. CGM devices offer the advantage of being
wearable biosensors that send data wirelessly to a display device through a transmitter. Despite their
advantages, these devices are still invasive and associated with some discomfort. Moreover, they show
biofouling effects due to surface deposition of proteins and cells [7].
Amperometric biosensors based on microneedles technology represent an interesting
compromise [8–10]. Like the CGM devices, microneedles-based biosensors allow for the continuous
monitoring of glucose in the ISF. However, thanks to their short length (1 mm), they can penetrate only
the first layer of the human skin, the epidermis (thickness between 50 and 500 µm) without penetrating
the second layer, the dermis (thickness in the range 500–2000 µm), unlike normal needles (6 mm in
length). The dermis is the most vascularized region of the human skin, whereas no blood vessels nor
nerve endings are present in the epidermis. According to these reasons, they are significantly less
painful than CGSs, improving comfort and treatment quality in patients affected by diabetes [11–13].
Moreover, they show minimized biofouling effects as they are changed every day compared to other
implantable devices that are changed every two weeks or more. Another important characteristic of
the microneedles-based biosensors is their high sensitivity; they provide larger currents thanks to their
larger electrode surface areas. Furthermore, they also showed high reproducibility during in vitro and
in vivo experiments [5,9], as well as simplicity and low cost in terms of production. They also cause
lower skin irritation and a lower risk of local infection and bleeding [14].
Microneedles-based devices were initially used as transdermal delivery systems of a number
of drugs and other compounds [10,14–17]. Subsequently, they were utilized for the development of
transdermal analytical sensors for pain-free detection of analytes of clinical relevance. Although most
studies apply the microneedle arrays for the continuous monitoring of glucose [9,11,18–25], a few
papers have also been published on the use of microneedles-based biosensors for the detection of other
bioanalytes, such as lactate [9,23,26–28], alcohol [29], beta-lactams [30], and glutamate [31]. Glucose
biosensors generally involve the detection of hydrogen peroxide produced by the reduction of oxygen
catalyzed by a GOx reaction. Unfortunately, it is known that the oxidation of hydrogen peroxide occurs
at a quite high overpotential at which other electroactive species can be oxidized [32,33]. The use of
a redox mediator allows us to lower the detection potential of glucose, thus reducing the possible
interferences with a consequent increase of the selectivity of the biosensor. Among the electroactive
groups, ferrocene and its derivatives have been extensively used as model systems to study the
reversible electron exchange between the mediator and gold electrodes, thanks to the simple and good
electrochemical characteristics of the ferrocene group [34–36].
Highly porous gold electrodes (h-PG) have pores in the micrometer range that increase drastically
the electrode surface area and the relative current densities [37,38]. Three main methods have been
generally used to fabricate porous gold films: de-alloying, electrochemical deposition, and templating.
De-alloying is a corrosive process of alloy components by selective dissolution of the most active
element in the alloy, which is gold, which could be done either electrochemically or chemically.
Electrochemical deposition is an electrodissolution–disproportion–deposition reaction between gold
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and HCl [39]. The templating method combines various techniques, such as the flow-stream technique,
sputter deposition, and electrochemical methods, and involves the following three steps: preparation
of the template, deposition of gold, and removal of the template. The self-templating method is a
simplified and time-saving templating method that involves only two steps: gold electrodeposition
and gas bubbling as a self-template [38,40–42].
In this work, a highly porous gold (h-PG) microneedles-based biosensor for minimally invasive
sensing of glucose in artificial interstitial fluid was realized and investigated. The h-PG surface was
developed by electrodeposition of a gold layer followed by hydrogen bubbling at the electrode surface
through applying a negative potential of −2 V versus a saturated calomel electrode (SCE) in a solution
containing NH4Cl as a supporting electrolyte and a hydrogen source. The h-PG microneedles were
characterized and compared to microneedles modified with multiwalled carbon nanotubes (MWCNTs)
and to a planar gold electrode before and after the modification with h-PG and MWCNTs. The flavin
adenine dinucleotide glucose dehydrogenase (FAD-GDH)/6-(ferrocenyl)hexanethiol (FcSH)/h-PG
microneedles-based electrode was successfully realized by immobilization of the redox mediator
6-(ferrocenyl)hexanethiol and the FAD-GDH enzyme [43]. An image of the microneedles and
a schematic representation of the as-assembled microneedles-based electrode are reported in
Figure 1A,B, respectively. To the best of our knowledge, this is the first example of a h-PG-modified
microneedles-based electrode reported in the literature. Finally, the feasibility of the developed
biosensor for minimally invasive monitoring of glucose was evaluated in artificial interstitial fluid and
in a simulated skin model.
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Figure 1. (A) Photo of four 4 × 4 microneedle arrays metallized with gold and silver; (B) Schematic
representation of the highly porous gold (h-PG)/6-(ferrocenyl)hexanethiol (FcSH)/flavin adenine
dinucleotide glucose dehydrogenase (FAD-GDH)/Au microneedles-based glucose biosensor. Figure 1A
is reproduced from ref. [28] with permission of Elsevier Science ltd (2019).
2. Results and Discussion
.1. SEM and Electrochemical Characterization of h-PG/Au Microneedles Electrodes
SEM experiments were carried out to investigate the morphology of the highly porous gold
microneedles-based electrode. SEM images of the bare and the h-PG-modified microneedles-based
electrode are pres ted in Figures 2A and 2B (ma . ×100 and mag. ×1000) and 2C (mag. ×1000),
respective y. It is possible to note the w ll-defined pores with diameters of approximate y 25 µm,
as sh wn in Figur 2C. The hi hly porous gold surface is probably obtained by the reduction of Au3+
ions to Au0 a oms with their subsequ nt aggr gati n and deposition on the ugh surface of the
microneedles electrode to form the porous str cture. A key point of the fabrication of the porous
surface is the choice of a suitable negative potential and the right time at which to apply it. A negative
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potential of −3 V generated hydrogen bubbling at the microneedles surface of the working electrode
that was too vigorous and destroyed the gold surface. A lower potential (about 0 V) was not enough
to generate the proper hydrogen bubbling to create the porous structure. The potential of −2 V was
therefore chosen as a compromise to guarantee a sufficient bubbling of hydrogen at the gold surface to
create the proper porous structure without ruining the surface itself. A time of 60 s was chosen as it is
the length of time that enabled the porous structure to entirely cover the electrode. Another important
parameter that was carefully optimized was the distance between the bottom of the microneedle arrays
structure and the beaker’s bottom. The highly porous gold surface was produced when this gap was
not greater than 3 mm, probably because a larger distance would not facilitate the diffusion processes
of H+, AuCl4, and Cl− ions towards and away from the electrode surface to enable the aggregation
and deposition of the gold atoms on the electrode surface to form the porous structure [44].
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Figure 2. SEM images of (A,B) a bare microneedles gold electrode and (C) an h-PG microneedles gold
electrode with differ nt magnifications. (A) 6.00 kV, mag. ×100; (B,C) 10.0 kV, mag. ×1000.
In order to demonstrate the improvements in the electrodeposition method in terms of electroactive
area, the gold film was characterized electrochemically in 0.5 M H2SO4 at a scan rate of 100 mV s−1.
The cyclic voltammogram shows two anodic peaks due to gold oxidation starting at about 1 V versus
SCE and one large cathodic peak at about 0.7 V versus SCE due to the reduction of the gold oxide
formed during the positive sweep, as shown in Figure 3A. The real surface area of the highly porous
gold electrode was calculated by integrating the charge required for reducing the gold oxide (Figure 3A,
red curve), and the results were compared with those obtained with a bare microneedles gold electrode
with the same geometric surface (Figure 3A, black curve). The h-PG microneedles electrode showed
a real surface area of 88.50 cm2, assuming that the charge density for the reduction of gold oxide is
390 µC cm−2, a value that is about 100 times higher compared to the bare microneedles gold electrode
(0.90 ± 0.02 cm2).
The real active area of the porous surface was also investigated by cyclic voltammetry in a
solution of Fe(CN)63−/4− (Figure 3B,C). A remarkable enhancement of the anodic and cathodic peak
current densities after the h-PG electrodeposition was observed as a consequence of the increase in the
electroactive surface area. By comparing these results with those obtained with a planar gold electrode
before and after the h-PG electrodeposition, it can be easily noted that the increase in the current
after the h-PG electrodeposition is larger in the case of the Au-microneedles electrode (Figure 3B)
compared to the Au-planar electrode (Figure 3C). The roughness factors of the two electrodes before
and after the electrodeposition of h-PG have been calculated, and the roughness factor after the
electrodeposition of h-PG resulted to be almost 20 times higher in the case of the microneedles electrode
(ρ = 1032.1 ± 2.3) compared to the planar electrode (ρ = 56.0 ± 0.8) (Table S1). The particular geometry
of the microneedles probably allows for a better electrodeposition of h-PG and therefore a larger
electroactive surface area is obtained. Table S1 also shows the electroactive area and roughness factor of
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the microneedles and planar gold electrodes modified by electrodeposition of Au-MWCNTs, according
to a procedure reported in our previous work [29], for comparison. It is interesting to note the large
enhancement of the roughness factor in the case of the h-PG microneedles-based electrode, which
results to be three times higher than that obtained with microneedles modified with Au-MWCNTs
(Figure 3B,C, blue curves). The heterogeneous electron transfer rate constants (k0, cm s−1) for the
planar gold and the microneedle gold electrodes before and after the modification with h-PG and
Au-MWCNTs are also reported in Table S1, calculated with a method proposed by Lavagnini et al.
that merges the Klingler–Kochi and Nicholson and Shain methods developed for irreversible and
reversible systems, respectively [45,46]. The Au microneedles/h-PG electrode showed the highest k0
value (k0 = 56.2 ± 0.5 × 103 cm s−1), attesting to faster electron transfer kinetics.Catalysts 2 19, 9, x FOR PEER REVIEW 5 of 15 
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to note that voltammograms sh w the typical shape f a surface-bound species with a small
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to be about +0.38 V versus SCE, in good agreement with the valu reported in the lit rature for this
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mediator [47]. An analysis of the Faradaic current as a function of v resulted in a linear relationship,
as shown in the inset of Figure 4, attesting to the typical dependence of the current on the scan rate of a
surface-confined mediator.
The effect of FcSH amount was investigated and the maximum current signal was obtained by
using an 8 mM FcSH solution for the mediator immobilization (data not shown). Higher amounts of
FcSH showed a decrease in current response, probably due to a steric hindrance effect of the mediator
on the microneedles electrode surface [48,49].
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Figure 4. Cyclic voltammograms obtained with a FcSH/h-PG/Au microneedles electrode at different
scan rates: 30 mVs−1 (yellow); 50 mVs−1 (green); 80 mVs−1 (black); 100 mVs−1 (blue); and 300 mVs−1
(red) in 50 mM PBS at pH 7.5. In the inset: the dependence of J on v relative to the different curves.
2.3. Application of the h-PG/Au Microneedles-Based Glucose Biosensor in Artificial ISF
Before studying the amperometric responses toward D-glucose of the assembled
FAD-GDH/FcSH/h-PG/Au microneedles-based glucose biosensor, the amount of loaded enzyme
was carefully examined and optimized by drop-casting onto the microneedles surface FAD-GDH
amounts varying from 1 to 5 U. The variations in the current densities as a function of the enzyme
loading are shown in Figure S1. The biosensor response increased proportionally with the enzyme
loading up to 1.5 U, corresponding to 5 µL of enzyme. A slight decline in the response signal is
observed at higher enzyme concentrations probably due to the rigid structure of the FcSH molecule,
showing a rate-limiting dependence on the enzyme concentration only at low loaded FAD-GDH
amounts. Therefore, 1.5 U was the concentration of enzyme utilized for the biosensor’s development.
Figure 5A shows a comparative cyclic voltammogram of the FAD-GDH/FcSH/h-PG
microneedles-based electrode in the absence and in the presence of glucose in artificial interstitial fluid.
A good electrocatalytic current was registered with an onset potential of +35 mV, in agreement with
the value reported in the literature for the redox potential of the FcSH mediator (E0 = +38 mV vs. SCE).
In Figure 5B, it is possible to observe that the calibration curve for glucose detection in artificial
interstitial fluid has an extended linear range between 0.1 and 10 mM glucose (inset Figure 5B) and
a sensitivity of 50.86 µA cm−2 mM−1 (R2 = 0.97, n = 5). The detection limit resulted to be 50 µM,
calculated using the relation 3σ/S, with σ and S the absolute standard deviation of the intercept and
the slope of the calibration curve, respectively. By fitting the calibration curve to the Michaelis–Menten
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kinetic parameters, a Jmax value of 520.20 ± 25.11 µA cm−2 was obtained and a Michaelis–Menten
constant (KM) of 11.75 ± 1.18 mM was calculated, showing a good affinity of the FAD-GDH enzyme
for glucose.
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2.4. Effect of pH and Temperature on the Stability and Selectivity of the Glucose Biosensor
The median pH and temperature values are important parameters for enzymes to maintain their
activities and catalysis efficiency. The optimum pH and temperature values for the FAD-GDH enzyme
in soluble form was found to be pH 7 and 35 ◦C, respectively [50]. A possible shift in optimal pH
can be obtained for immobilized enzymes. The pH effect was studied by varying the pH of the ISF
in the range between 3 and 9, using acetate, phosphate, and TRIS buffer. The maximum current
responses were obtained in phosphate buffer pH 7.5 (Figure 6A) at 35 ◦C (Figure 6B). These results are
of great consequence for a potential application of the microneedles-based biosensor under human
physiological conditions.
An important requirement for a microneedles-based biosensor for transdermal analysis is the
ability to operate over several days with no significant decrease in its response. The stability was
examined using a 0.2 mM glucose solution over 30 days by using the biosensor in continuous operation
for 10 measurements every day. A high stable current response was obtained over the whole period,
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with a decrease in the initial signal response of about 20% after 30 days (Figure 6C). Such a high lifetime
of the biosensor probably reflects the stability of the enzyme in the highly porous structure of the
microneedles electrode surface.
Another important feature of a microneedles-based biosensor is the capacity to avoid interference
from other electroactive compounds present in the human interstitial fluid. The response of the proposed
biosensor was evaluated with a standard glucose concentration and with equal concentrations of
exogenous interfering compounds, such as d-fructose, d-mannitol, d-galactose, and ascorbic acid.
These compounds have a similar oxidation potential to glucose and could affect the biosensor’s current
response. Figure 6D shows the high selectivity of the proposed biosensor, as no tested compound
showed any significant current signal with the exception of ascorbic acid, whose signal was, however,
about 10% of the signal obtained for glucose. Also, xylose and maltose were tested, but they did not
show any current signal, confirming the high selectivity of the proposed biosensor.
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An analytical comparison with the results obtained with other microneedles-based glucose
biosensors recently reported in the literature is shown in Tables 1 and 2. It is interesting to note that
most microneedles-based biosensors show extended linear ranges and high sensitivities; however, they
are based on the oxidation of H2O2 (first-generation biosensors), which occurs at high overpotentials
with the obvious drawback of the possibility of side reactions, such as the oxidation of ascorbic acid,
lactic acid, and uric acid, thus hampering the selectivity of the biosensor [51–55]. The second-generation
FAD-GDH/FcSH/h-PG/Au microneedles-based biosensor proposed in this study exhibits a linear range
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and a sensitivity comparable to the devices based on the “first generation” biosensor mechanism
without the drawback of the high overpotential and the dependence on oxygen concentration, extremely
important requirements for a subcutaneous biosensor, while maintaining at the same time a much larger
linear range compared to the second-generation microneedles-based biosensor based on MWCNTs
reported in the literature [23,56].
Table 1. Heterogeneous electron transfer rate constant (k0), real electroactive area (AEA), and roughnesss
factor (ρ) of the gold planar electrode and the gold microneedles-based electrode before and after the
electrodeposition of h-PG and Au-MWCNTs. Ageo planar Au electrode = 0.020 cm2; Ageo microneedle
electrode = 0.2 cm2.
Electrode k0/10−3 cm s−1 AEA/cm2 ρ
Au planar electrode 1.1 ± 0.1 0.08 ± 0.01 4.0 ± 0.2
Au planar electrode/h-PG 3.0 ± 0.8 1.12 ± 0.02 56.0 ± 0.8
Au planar electrode/Au-MWCNTs 2.7 ± 0.9 1.24 ± 0.02 39.5 ± 0.6
Au microneedles 5.8 ± 0.2 2.02 ± 0.18 10.1 ± 0.6
Au microneedles/h-PG 56.2 ± 0.5 206.42 ± 0.42 1032.1 ± 2.3
Au microneedles/Au-MWCNTs 16.3 ± 0.4 60.36 ± 0.31 301.6 ± 1.6
Table 2. Comparison between different microneedles-based biosensors for glucose detection.
Microneedles Biosensor
Platform
Detection
Technique
Linear Range
(mM)
Biosensor
Type
Real
ApplicAtion Ref.
Au/PEGDA/vFc/GOx amperometry 0–0.6 first generation - [51]
Au/FcCOOH/GOx amperometry 2–13.5 first generation - [52]
C/CMC/GOx amperometry 0–35 self-powered - [21]
AuNPs-PtNPs/PANI/PtNPs/
GOx/PVDF-Naf amperometry 0–20 first generation in vivo [53]
Au/MPA/GOx Cyclicvoltammetry 2.8–22.2 first generation in vitro [54]
Au/PP/GOx amperometry - first generation in vivo [5]
CP/GOx/TTF-CP/Pt black polarizationcurve 0–25 self-powered - [19]
Au/pTCA-GOx amperometry 0.05–20 first generation - [55]
GDH/pMB/AuMWCNTs/Au amperometry 0.05–5 secondgeneration - [23]
FAD-GDH/FcSH/h-PG/Au amperometry 0.1–10 secondgeneration - this work
List of abbreviations: MPA, 3-mercaptopropionic acid; PVDF, three-dimensional (3D) porous polyvinylidene
fluoride; C, carbon-based electrode; CP, carbon paste; CMC, carboxymethyl cellulose; PP, electropolymerized
polyphenol; FAD-GDH, FAD-glucose dehydrogenase; FcCOOH, ferrocene monocarboxylic acid; GOx, glucose
oxidase; Au, gold electrode; AuNPs, gold nanoparticles; Naf, nafion; Pt black, platinum black; Pt-c, platinum
carbon electrode; PtNPs, platinum nanoparticles; PANI, polyaniline; PEGDA, polyethylene glycol diacrylate;
TTF, tetrathiafulvalene; vFc, vinylferrocene; BSA, bovine serum albumin; GA, glutaraldehyde; TCA, terthiophene
carboxylic acid; pMB, polymethylenblue.
2.5. Simulation of Continuous Glucose Monitoring Using a Skin Model
The feasibility of the FcSH/h-PG/Au microneedles-based biosensor for continuous glucose
monitoring was tested in flow conditions for 12 h through the determination of the glucose
concentrations in a skin model, consisting of a chitosan/agarose hydrogel opportunely embedded in
artificial ISF at two different glucose concentrations, 4 mM and 8 mM, in order to simulate the normal
glucose levels in a healthy patient under fasting conditions (in the morning before breakfast) and
after lunch (approximately 6 h after breakfast). Both current signals presented a lag-time of about
2 min compared to the experiments performed in solution, possibly because of the time of diffusion of
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glucose through the hydrogel; the signals resulted to be quite stable, thus attesting to the robustness of
the developed device. The current signal registered for the 8 mM glucose concentration resulted to be
about 2 times higher than that registered at the 4 mM glucose concentration, confirming that the two
concentrations fall perfectly into the linearity range of the glucose biosensor (0.1–10 mM).
3. Materials and Methods
3.1. Reagents and Apparatus
3-(N-morpholino)propanesulfonic acid (MOPS), 4-(2-Hydroxyethyl)piperazine-1-ethanesulfonic
acid (HEPES), ammonium chloride (NH4Cl), ascorbic acid (AA), boric acid, calcium chloride
(CaCl2), d-(−)-glucose (Glc), ferricynide (Fe(CN)63−), ferrocyanide (Fe(CN)64−), magnesium sulfate
(MgSO4), 6-(ferrocenyl)hexanethiol (FcSH), potassium chloride (KCl), potassium nitrate (KNO3),
saccharose, agarose, chitosan with medium molecular weight, sodium acetate (CH3COONa), sodium
tetraborate, sodium chloride (NaCl) sodium l-lactate, sodium phosphate dibasic (Na2HPO4),
sodium phosphate monobasic (NaH2PO4), sulfuric acid (H2SO4), hydrochloric acid (HCl),
tris(hydroxymethyl)aminomethane (TRIS), uric acid (UA), D-fructose, D-galactose, D-mannitol,
and tetrachloauric acid (HAuCl4) were purchased from Sigma Aldrich (St. Louis, MO, USA).
FAD-glucose dehydrogenase (FAD-GDH) from Aspergillus niger was obtained from Creative
Enzyme Ltd. The FAD-GDH (activity 300 U/mL) was solubilized in a 10 mM PBS buffer (pH 7.5) and
stored at −20 ◦C until further use.
To prepare the artificial interstitial fluid (ISF), 2.5 mM CaCl2, 10mM Hepes, 3.5 mM KCl, 0.7 mM
MgSO4, 123 mM NaCl, 1.5 mM NaH2PO4, 7.4 mM saccharose were mixed, and the solution was
adjusted to pH 7.5. Milli-Q water (18.2 MΩ cm, Millipore, Bedford, MA, USA) was used to prepare
all solutions.
All electrochemical experiments were performed using a PGSAT204N potentiostat (Eco Chemie,
The Netherlands) equipped with Nova 2.1 software (Eco Chemie, The Netherlands). All potentials are
referred to a saturated calomel electrode (SCE, 244 mV vs. NHE, Cat. 303/SCG/12, AMEL, Milano, Italy).
Moreover, gold planar- or microneedle-based electrodes and a glassy carbon rod electrode (d = 2 mm,
Cat. 6.1241.020, Metrohm, Herisau, Switzerland) were employed as working and counter electrodes,
respectively. The temperature was controlled using a thermostatic bath (T ± 0.01 ◦C, LAUDA RM6,
Delran, NJ, USA).
The morphology of the electrodes was investigated by using High-Resolution Field Emission
Scanning Electron Microscopy (SEM) (HR FESEM, Zeiss Auriga Microscopy, Jena, Germany).
All samples were prepared using gold slides (25 Å~ 25 Å~ 1 mm, ALS Co. Ltd., Tokyo, Japan)
and microneedles electrodes.
3.2. Modification of Au Microneedles-Based Electrode
The microneedles-array Au microneedles electrodes were kindly provided by a collaborator at
Glasgow University [25,43]. These electrodes are based on a polycarbonate scaffold (0.5 × 0.5 × 0.02 cm)
with 64 microneedles divided as four 4 × 4 arrays. Each pyramid showed the following dimensions:
base 0.06 cm; height 0.1 cm; 4 × 4 array area 0.2 cm2. On this platform, three electrodes were used as
working electrodes (gold), while the fourth electrode was the reference electrode (silver). However, in
the present work, we used an external saturated calomel electrode as a reference electrode to run the
preliminary experiments.
At the beginning, the microneedles electrodes were electrochemically cleaned by sweeping the
potential between −0.3 and 1.7 V versus SCE 20 times at a scan rate of 300 mV s−1 in 0.5 M H2SO4.
The electrodeposition of highly porous gold (h-PG) was performed by cycling the potential between
+0.8 and 0 V versus SCE for 25 scans at 50 mV s−1 in a solution containing 10 mM HAuCl3 and
2.5 M NH4Cl. Afterwards, a fixed potential of −2 V versus SCE was applied in the same solution in
order to activate the self-templated formation of pores. Next, the electrodes were activated in 0.5 M
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H2SO4 by running CVs between 0 and +1.7 V versus SCE at a scan rate of 100 mV s−1 for 25 cycles.
All the electrochemical parameters (e.g., electroactive surface area, heterogeneous electron transfer
rate constant (k0, cm s−1), and roughness factor (ρ)) were obtained in 5 mM Fe(CN)63−/4− (50 mM PBS
buffer pH 7.5 + 137 mM NaCl). Furthermore, the as-prepared h-PG/Au microneedles electrode was
modified through self-assembling monolayer formation by incubating the electrode in an 8 mM FcSH
solution overnight. After thoroughly washing the electrode with working buffer, 5 µL of FAD-GDH
enzyme were cast onto the modified electrode.
3.3. Modification of Au Planar Electrode
Planar gold electrodes (AuE) (d = 1.6 mm, AMEL, Milano, ITALY) were carefully cleaned with
Piranha solution (1:3 mixture of conc. H2O2 with H2SO4, CAUTION: Piranha solution is especially
dangerous, corrosive and may explode if contained in a closed vessel, it should be handled with special care).
Afterwards, they were mechanically cleaned with polishing cloths and deagglomerated alumina slurry
of 1 µm in diameter (SIEM, Bologna, ITALY), and successively sonicated in ultrapure water for 5 min.
Next, the electrodes were electrochemically cleaned by sweeping the potential in the range between
−0.3 and 1.7 V versus SCE at a scan rate of 300 mV s−1 M for 20 cycles in 0.5 M H2SO4. The h-PG
surface was realized by a self-templating method, as reported above. The as-modified electrodes were
characterized and modified following the microneedles protocol reported in the previous section.
4. Conclusions
In this work, we described the fabrication and characterization of a novel glucose biosensor based on
microneedles technology. The novelty of the work consists in the realization of a h-PG gold microneedles
electrode and in the use of the mediator 6-(ferrocenyl)hexanethiol, thus realizing a second-generation
biosensor with improved performance in terms of linear range, sensitivity, and selectivity. The highly
porous film was electrochemically fabricated through a deposition/self-templating method that made
the active surface area of the microneedles electrode up to 100 times larger than that of a classical
bare one, thus enhancing the sensitivity of the biosensor. The device was tested in artificial interstitial
fluid, showing good repeatability and good long-term stability, and also under simulated continuous
monitoring conditions in a chitosan/agarose hydrogel skin model. The obtained results are encouraging
for the use of the proposed microneedles-based biosensor as a wearable device to be used in medicine
for the continuous monitoring of glucose in patients with diabetes. Investigation of in vivo performance
through experiments in healthy and diabetic volunteers will be the next aim of the work. Further work
will be devoted also to the realization of toxicity tests of the developed device, on the one hand, as
well as to studies of a possible integration of suitable electronics for wireless communication, on the
other hand.
Supplementary Materials: The following are available online at http://www.mdpi.com/2073-4344/9/7/580/s1,
Figure S1: Effect of enzyme loading on biosensor response, Table S1: Heterogeneous electron transfer rate
constant (k0), real electroactive area (AEA), and roughness factor (ρ) of a gold planar electrode and a gold
microneedles-based electrode before and after the electrodeposition of h-PG and Au-MWCNTs.
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